Spanish for endocrinology clinic nurses: the patient who reduced her insulin because she ate too much sweet, the patient who skips mealtime doses when he feels fine, and the patient who stopped coming when the CGM became unaffordable

Marisol Vega was fifty-eight years old, a retired school cafeteria worker from Modesto. She had been diagnosed with Type 2 diabetes fourteen months ago. She had been started on metformin and then, four months ago, on basal insulin — glargine, ten units at bedtime — after her A1c came back at 9.6. She had not fully understood why. Her neighbor Dolores had Type 1 diabetes and had used insulin since she was a child. Marisol had thought of diabetes in two categories: the kind where you need insulin, and the other kind. She had been told she had “the other kind.”

She came to the endocrinology clinic for her quarterly follow-up with a glucose log she had kept faithfully and a question she had not asked the physician because she did not know how to phrase it. During the nursing intake, the nurse reviewed the log and noticed three days the prior week where fasting glucose was elevated — between 180 and 220 — following a period of normal readings. The nurse asked what had happened that week.

Marisol said: “La semana pasada fue el cumpleaños de mi nieto. Comié demasiado dulce. Así que le bajé un poco a la insulina. Pensé que si comí más dulce, menos insulina era mejor — que si ya ponía más azúcar, la insulina no debía poner más.”

The nurse paused. She said: “¿Le bajó a la insulina cuando comió el pastel?”

“Sí. Porque si ya puse demasiado azúcar, no quería que la insulina pusiera más.”

Three endocrinology clinic patterns that appear in the quarterly visits no one trains for: Marisol, who reduced her basal insulin every time she ate something that raised her glucose, because she believed insulin added sugar to the blood; Ernesto Pérez, 67, retired bus driver from Bakersfield, who skipped mealtime rapid insulin on any day he felt asymptomatic, because he believed his body would warn him before the glucose number mattered; and Carmen Delgado, 51, bakery owner from Fresno, who stopped coming to the endocrinology clinic for four months after losing her continuous glucose monitor coverage and returned after a nocturnal hypoglycemia episode she managed alone, in the dark, with crackers from a box she kept on the nightstand.

The patient who reduced her insulin because she ate too much sweet

Marisol had not invented her belief about insulin. She had absorbed it from a reasonable misreading of the information she had been given. She understood that insulin was associated with sugar. She understood that the goal was to keep sugar low. She understood that she had eaten cake. The conclusion she had drawn — reduce insulin when sugar intake goes up — was internally consistent with those three premises. It was also the opposite of correct, and had produced elevated fasting glucose on three consecutive mornings.

The nurse said: “Voy a explicarle cómo funciona la insulina, porque lo que me está diciendo me dice que hay algo importante que nadie le ha explicado todavía.” (I am going to explain to you how insulin works, because what you are telling me tells me there is something important that no one has explained to you yet.) She did not say Marisol had done something wrong. She said there was something no one had yet explained.

First, the basic mechanism, in patient language:

“La insulina no es azúcar — es la llave que abre la puerta para que el azúcar que ya está en la sangre pueda entrar a las células. Cuando usted come pastel, el azúcar sube en la sangre. La insulina es lo que saca el azúcar de la sangre y lo pone adentro de las células donde el cuerpo lo puede usar como energía. Si usted le baja a la insulina cuando come más dulce, el azúcar se queda en la sangre sin tener cómo salir.”

(Insulin is not sugar — it is the key that opens the door so that the sugar already in the blood can enter the cells. When you eat cake, blood sugar rises. Insulin is what takes the sugar out of the blood and puts it into the cells where the body can use it as energy. If you reduce the insulin when you eat more sweet things, the sugar stays in the blood with no way out.)

Marisol listened. She was quiet for a moment. Then she said: “¿O sea que la insulina no es lo que me pone el azúcar?”

“No. El azúcar viene de lo que usted come, y también del hígado — el cuerpo produce azúcar incluso sin comer. La insulina es lo que lo saca. Sin insulina, el azúcar que ya está ahí no tiene cómo moverse.”

Second, the Type 1 / Type 2 distinction, without using the informal shorthand that had caused the confusion in the first place:

“Usted mencionó que pensó que la insulina era para el otro tipo de diabetes. Voy a explicarle la diferencia. En la diabetes Tipo 1, el cuerpo no produce insulina en absoluto — el sistema inmune ataca el páncreas y éste deja de producirla completamente. En la diabetes Tipo 2 — que es la que usted tiene — el cuerpo sí produce algo de insulina, pero o no produce suficiente, o las células no responden tan bien como deberían. Con el tiempo, el páncreas se puede cansar un poco de trabajar más duro de lo normal. Cuando eso pasa, la insulina extra que le recetamos no es un castigo por comer mal — es la herramienta que el páncreas ya no puede fabricar por sí solo en las cantidades que el cuerpo necesita.”

Marisol: “¿O sea que no es que tengo la ‘peor’ diabetes?”

“No. El Tipo 1 y el Tipo 2 son mecanismos diferentes con tratamientos diferentes. Que usted necesite insulina ahora no significa que falló en el manejo de la diabetes. Significa que el tratamiento avanzó al siguiente paso, que es lo que pasa en muchas personas con Tipo 2 con el tiempo.”

Third, the correct response to a high-carbohydrate meal — stated simply and without equivocation:

“Cuando sepa que va a comer algo que sube el azúcar, no le baje a la insulina — es al revés. La insulina basal que le recetamos trabaja durante todo el día, no solo después de la comida. Si usted tiene alguna duda sobre si necesita ajustar la dosis algún día, la llama a la clínica o lo habla en la próxima cita. Pero nunca la baje por su cuenta porque comió algo dulce — eso hace lo contrario de lo que queremos.”

Teach-back, not as a quiz but as a rehearsal: “¿Puede explicarme, con sus propias palabras, para qué sirve la insulina?” Marisol said: “Para sacar el azúcar de la sangre y meterlo a las células. No para ponerlo — para sacarlo.”

“Exacto. Eso es exactamente lo que hace.”

The nurse wrote in the chart: “Patient was adjusting basal insulin downward on days of increased carbohydrate intake, based on a belief that insulin adds glucose to the blood. Education provided on insulin mechanism (insulin as the key that removes glucose from bloodstream, not adds it). Patient verbalized correct understanding at teach-back: ‘Para sacarlo, no para ponerlo.’ Chart note so endocrinologist can reinforce at this visit. Fasting glucose elevations on 2026-06-18 through 2026-06-20 now explained by three days of basal dose reduction during patient’s grandson’s birthday celebration.”

At the six-month follow-up, Marisol’s A1c had dropped from 9.1 to 7.8. She came in with a new page in her glucose log that she had added herself — a column for what she had eaten — and a note at the top in her handwriting: “La insulina saca, no pone.” She had written it there after the visit. She had not reduced her dose since.

The patient who doses by how he feels instead of by his glucose number

Ernesto Pérez was sixty-seven years old, a retired bus driver from Bakersfield. He had Type 2 diabetes, diagnosed twelve years ago. He had been on metformin and glipizide for nine of those years, and three years ago his A1c had continued to climb despite maximum oral doses. His endocrinologist had added mealtime rapid-acting insulin — aspart, four units before each meal, with instructions to test before eating. His A1c at that transition had been 8.7. It was now 8.9 and had not moved in six months.

During the nursing intake, the nurse reviewed his insulin log. There were gaps — three and four consecutive days with no mealtime entries, clustered on weekdays when, he explained, he ate at the same time every day and felt well.

The nurse asked: “Veo que hay varios días donde no hay registro de la insulina de las comidas. ¿Me puede contar qué pasa esos días?”

Ernesto said: “Cuando me siento bien, no me la pongo. Si me siento normal, el azúcar debe estar bien. Yo sé cuándo el azúcar está alto porque me siento mal. Los días que me siento bien, no me parece que tenga sentido ponerme algo que no necesito.”

He had not said this to anyone before. He thought it was a reasonable clinical judgment. Twelve years of diabetes management had not included a conversation about asymptomatic hyperglycemia in language that had changed his behavior.

The nurse said: “Eso que me está diciendo es importante, y quiero explicarle algo sobre la diabetes que es difícil de entender porque va en contra de lo que el cuerpo le dice. ¿Me da unos minutos?”

Ernesto said yes. The nurse said:

“El azúcar alto en la sangre no siempre se siente. Muchas personas con Tipo 2 — especialmente después de varios años con la enfermedad — pueden tener el azúcar en 250, en 300, y sentirse completamente normales. No con náuseas, no con mareo, no con sed. Solo... normales. El cuerpo se acostumbra a vivir con azúcar alto, y cuando se acostumbra, ya no da la señal de alerta que uno esperaría. La señal de alerta que usted conoce — sentirse mal — aparece cuando el azúcar está muy, muy alto. Pero el daño que el azúcar le hace a los vasos sanguíneos, a los riñones y a los nervios pasa con números de 200 a 300 — números que muchas personas no sienten pero que sí dejan huella.”

Ernesto listened. He said: “Pero yo he sentido cuando estaba muy alto — me sentí terrible una vez, hace como cinco años.”

“Sí — cuando el azúcar está muy alto, hay síntomas. Lo que le estoy diciendo es que hay un rango — de 200 a 300 — donde muchas personas se sienten normales pero el daño sí está pasando. Ese rango es donde viven muchos de sus días sin la insulina de las comidas.”

Then the stakes, in concrete and personal terms. The nurse had read the chart. Ernesto had been a bus driver for thirty-two years. He had driven the same route for eighteen of them. He had retired two years ago, healthy enough to be proud of the retirement.

“Le pregunto algo, Ernesto. Usted manejo el autobús por treinta y dos años. Los pasajeros que subían — usted los podía ver bien, identificar los billetes, ver las señales del tráfico con claridad?”

“Sí, perfectamente.”

“Eso importa en la diabetes. La diabetes que no está controlada puede afectar los vasos sanguíneos de la retina — la parte de atrás del ojo que hace posible la visión. No siempre duele. Muchas veces no lo va a notar en un espejo. Pero hay cambios que un oftalmólogo puede ver antes de que usted los sienta. ¿Ha ido al oftalmólogo para la revisión de diabetes en el último año?”

Ernesto had not been for two years. He had thought his vision was fine. The nurse noted this in the chart — ophthalmology referral delinquent by two years — and flagged it for the endocrinologist to address in the same visit.

“No le pido que se ponga la insulina a ciegas. Le pido que mida el azúcar primero. Si el número está alto, la insulina la necesita aunque se sienta bien. Si el número está en rango, habla con su médico sobre si se puede ajustar la dosis. Pero la decisión tiene que venir del número, no de cómo se siente. Su cuerpo ya no le está enviando esa señal de alerta de manera confiable.”

Ernesto: “No sabía que el cuerpo podía acostumbrarse así. Pensé que siempre me iba a avisar.”

The nurse’s chart note: “Patient has been withholding mealtime insulin aspart on days he feels asymptomatic, based on a belief that absence of symptoms indicates acceptable glycemia. Education provided on asymptomatic hyperglycemia — that glucose can remain at 200–300 without producing symptoms the patient can reliably identify, while microvascular damage accumulates. Connected specifically to patient’s thirty-two years as a bus driver and expressed pride in his vision. Patient understood and verbalized: ‘el cuerpo ya no me avisa.’ Ophthalmology referral delinquent x2 years — recommend generating referral this visit.”

At the next quarterly visit, Ernesto’s A1c was 8.1. He had been taking his mealtime doses on most days. He said: “Ya entendí que sentirse bien no significa que está bien. Es al revés de lo que uno piensa.”

The ophthalmology referral had been completed. The report: mild nonproliferative diabetic retinopathy, bilateral, no treatment required at this stage, annual follow-up recommended. Ernesto read “no treatment required at this stage” and understood that this was the benefit of catching it now. He came back to the endocrinology clinic with the ophthalmology report in a folder he had made.

The patient who stopped coming when the CGM became unaffordable

Carmen Delgado was fifty-one years old, a bakery owner from Fresno. She had been diagnosed with Type 2 diabetes eleven years ago. For the first six years her control had been inadequate on oral medications alone — multiple A1cs above 9 — partly because of the medication, and partly because she was managing a small business, raising two teenagers, and measuring glucose by how she felt. Three years ago, after a hospitaliza­tion for a hyperglycemic crisis, her endocrinologist had started her on a basal-bolus insulin regimen and had written a CGM prescription. She had learned to read the CGM overnight trends. She had learned what it looked like when dinner was raising her glucose too fast. She had called the device her “segundo par de ojos.” Her A1c had come down from 10.2 to 7.4 in eighteen months.

Four months ago, her husband’s employer changed health plans during open enrollment. The new plan did not cover CGM sensors as a durable medical equipment benefit for Type 2 diabetes. Out-of-pocket cost for the sensor brand she had been using: approximately $350 per month. She had paid for one month out of pocket. She had not been able to sustain it. She had used her last sensor in February.

She had not called the clinic to reschedule her March quarterly appointment. She had not left a message. She had not told the clinic why. She had simply stopped coming.

She returned in late June — four months later — because she had woken at three in the morning trembling and confused, sweating through her nightgown, and had eaten crackers from a box she kept on the nightstand. She had not tested because she had run out of test strips as well. She had not called the clinic that morning because she felt better after the crackers and did not want to bother anyone. She came to the clinic because she had also run out of her long-acting insulin and needed a prescription refill.

The nurse opened the visit the way she opened every visit with a patient who had been missing for several months: not with “why didn’t you come back?” — which produces defensiveness in a patient who already feels she has failed — but with:

“Hace cuatro meses que no la vemos. ¿Qué ha pasado desde entonces?”

Carmen said: “Se me acabaron los sensores. No los cubro con el seguro nuevo. Trescientos cincuenta dólares al mes — no puedo. Y sin los sensores no sé cómo manejar el azúcar. Todo lo que aprendí lo aprendí con el monitor. Sin él no sé cuándo está subiendo, cuándo está bajando. Así que dejé de venir porque no sabía qué decirle.”

The nurse heard the full sentence. She noted the structure of what Carmen had said: the financial barrier named first, but the clinical helplessness named second — “no sé qué decirle.” Carmen had not called because she did not know what she would say. She had not framed this as a problem the clinic could help with. She had framed it as a failure she was not ready to name.

“La entiendo. Y tiene razón en que es diferente manejar la diabetes sin el monitor. Usted aprendió a leer sus tendencias — cuándo sube de noche, cómo responde a las comidas. Eso no desaparece cuando se acaba el sensor. Eso está en lo que usted sabe ahora. Lo que perdió es la herramienta, no lo que aprendió con ella.”

Carmen: “¿Pero cómo voy a saber si el azúcar está bajando de noche si no tengo la alarma?”

That was the real question.

The nurse first addressed the safety question directly. She asked Carmen to walk her through the nocturnal hypoglycemia episode: when it happened, what she felt, how long it took to resolve, whether she had been able to get to the kitchen. Carmen described waking at 3 a.m., trembling, confused, unable to identify initially what was happening. She had eaten crackers because they were there. She had felt better within fifteen minutes. She had not called anyone.

“Lo que me describio es una hipoglucemia que necesita atención. Y vamos a hacer algo concreto hoy para que eso no vuelva a pasar.”

Four concrete actions in that visit:

A glucometer and strips, prescribed today. “No es lo mismo que el monitor que tenía — no le da las tendencias, no le avisa si está bajando. Pero le dice el número cuando lo necesita. Y ahora mismo, lo que necesita es el número. Cuatro veces al día: antes del desayuno, antes del almuerzo, dos horas después de la cena, y si se despierta sintiendo algo raro de noche.”

Insulin dose review. The nurse reviewed Carmen’s basal and bolus doses. Carmen had continued her basal dose unchanged. But she had stopped taking her bolus doses for most meals — because she could not see the postprandial spike without the CGM, she did not know if the food was raising her glucose, so she had decided not to treat what she could not see. The nurse noted this pattern: appropriate caution in a patient who had been trained to dose by CGM visual trend, now producing uncontrolled postprandial hyperglycemia she was not aware of and not addressing. The nurse wrote a simplified correction scale for mealtime dosing based on the pre-meal glucose number from the glucometer. “No necesita ver la subida para tratar la comida. Necesita el número antes de comer, y este esquema le dice cuánto poner según ese número.”

Social worker consult, same day. The clinic social worker had information on two programs: the CGM manufacturer’s patient assistance program, which Carmen was likely eligible for given the reduction in her bakery hours since losing the primary insurance benefit; and a savings card program from a second CGM brand that the endocrinologist had agreed was an acceptable alternative for her management pattern. The nurse placed the social work referral while Carmen was still in the room. “La trabajadora social la puede ver hoy antes de salir. No le garantizo nada — pero hay programas que no sabemos si aplican hasta que los revisamos.”

Follow-up in six weeks, not three months. “Después de cuatro meses sin el monitor y con la hipoglucemia de la semana pasada, no podemos esperar tres meses para saber cómo va. Seis semanas — y si pasa algo antes, llama primero.”

The nurse’s chart note: “Patient returned after 4-month gap precipitated by loss of CGM sensor coverage ($350/month, new employer plan). During gap, patient omitted most mealtime bolus doses — unable to visualize postprandial trends without CGM, chose not to treat what she could not see. Nocturnal hypoglycemia episode reported (date: approx. 2 weeks prior) — managed at home without testing, resolved with oral glucose. Glucometer and strips ordered. Simplified correction scale written. Basal dose reviewed — held at current dose pending A1c and glucose log review. Social work consult placed same day for CGM patient assistance programs. Follow-up 6 weeks.”

At the six-week follow-up, Carmen had been testing four times per day. The social worker had enrolled her in the CGM manufacturer’s patient assistance program — a ninety-day supply of sensors at no cost, with a bridge to a co-pay assistance program if coverage was not restored. She had not had another hypoglycemia episode. She was using the correction scale the nurse had written. She said: “Sigo extrañando el monitor — te avisa antes de que pase. Pero ya no manejo a ciegas.”

The A1c had come back at 8.3 — up from 7.4, but not as high as the clinic had feared given the four-month gap. The CGM sensors from the patient assistance program were in the mail. Carmen made her next appointment before leaving the building.

Three questions for every endocrinology clinic visit with a Spanish-speaking patient

These three questions are not a screening tool. They are designed to surface the three most common gaps that a standard quarterly-visit structure will not reach in a Spanish-speaking patient with insulin-dependent diabetes.

(1) “¿Hay algo que haya hecho diferente con la insulina o los medicamentos esta semana — algún ajuste que haya hecho por su cuenta?” (Has there been anything you’ve done differently with your insulin or medications this week — any adjustment you’ve made on your own?)

The phrase “ajuste que haya hecho por su cuenta” names self-adjustment without implying violation. The patient who reduced her basal insulin three times during the birthday week would not have answered “¿está tomando los medicamentos como le indicaron?” with anything other than yes — because from her perspective, she was being careful. She would answer this question because it names what she did as an adjustment, not a failure.

(2) “¿Hay días en que el azúcar se siente normal y usted decide no ponerse la insulina de las comidas? ¿O días en que no mide porque se siente bien?” (Are there days when your blood sugar feels normal and you decide not to take your mealtime insulin? Or days when you don’t test because you feel fine?)

The symmetrical construction captures both of Ernesto’s patterns: skipping the dose and skipping the test. Both had the same internal logic — no symptoms means no need. Neither would surface in a standard medication-adherence question because both felt like appropriate judgment rather than non-adherence. The patient who admits to one usually admits to the other.

(3) “¿Ha habido algo en los últimos meses que haya hecho más difícil seguir el tratamiento — el costo de los medicamentos, del monitor, de las tiras? ¿Hay algo que se haya tenido que dejar de usar porque no lo cubre el seguro?” (Has there been anything in the last few months that has made it harder to follow the treatment — the cost of medications, the monitor, the strips? Is there anything you’ve had to stop using because insurance doesn’t cover it?)

This question names cost directly and by category. Carmen did not call the clinic to say she had lost her CGM coverage. She stopped coming. This question, asked at the quarterly visit in March, would have caught the gap before the four-month absence and the nocturnal hypoglycemia episode. The category list — medicamentos, monitor, tiras — gives the patient a specific vocabulary rather than requiring her to volunteer the word she does not know how to say in a clinical context.

The three questions take less than three minutes. They have the potential to surface an insulin-mechanism misconception before it produces three consecutive elevated fasting readings, identify a symptomatic-dosing pattern before it prevents a stable A1c from improving, and catch a coverage gap before the patient is managing an insulin regimen entirely without feedback for four months. None of that information surfaces in a structured intake that reviews the medication list and moves to vitals.

What endocrinology nursing requires with Spanish-speaking patients on insulin

Marisol, Ernesto, and Carmen each had a gap that had been open for months before it became visible. In each case, the gap had a specific shape: a belief about how insulin works, a system for judging glucose that bypassed the measurement, a loss of an essential tool that produced a clinical consequence no one at the clinic knew had occurred. In each case, the gap had not been a secret. It had just not been named in the intake because no one had asked the question that would have named it.

Insulin management in a second language carries a compounding factor that does not appear in the medication list. The patient who learned the basic explanation of how insulin works in a rapid discharge education session, through an interpreter on a phone held by the bedside nurse, retained what she retained — which was not necessarily the mechanism, and not necessarily the part about what to do when she eats something that raises her glucose. The patient who was taught to dose by CGM trend and then lost the CGM did not learn a backup system because no one anticipated she would need one. The patient who has been told for twelve years that he should take his insulin as prescribed but has never been told that the absence of symptoms does not mean the absence of damage has built a management system that is coherent, internally consistent, and wrong in a way that has clinical consequences.

The insulin education that closes Marisol’s gap is two sentences and a metaphor: the key and the door. The asymptomatic hyperglycemia explanation is one mechanism and one personal stake: thirty-two years of good vision on a Bakersfield bus route. The CGM-access conversation is one non-judgmental question and four concrete actions that fit in a single visit. None of it required additional appointment time. It required the question that opened the topic before the topic became urgent.

Marisol said the thing that stays with this post: “La semana pasada comí demasiado dulce, así que le bajé un poco a la insulina.” She was trying to do the right thing. She had a model of how insulin worked that led her to do the wrong thing, and she would have continued doing it indefinitely if the intake question had been “are you taking your medications as prescribed?” instead of “has there been anything you’ve done differently this week?”

That is the difference between an intake that checks adherence and a conversation that checks understanding. In endocrinology nursing with Spanish-speaking patients on insulin, the difference matters every quarter.